Journal article
The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference
Abstract
PurposeRecombinant activated factor VII (rFVIIa) is currently not approved by Health Canada or the Food and Drug Administration for treating excessive blood loss in nonhemophiliac patients undergoing on-pump cardiac surgery, but is increasingly being used “off-label” for this indication. A Canadian Consensus Conference was convened to generate recommendations for rFVIIa use in on-pump cardiac surgery.Methods: The panel undertook a literature …
Authors
Karkouti K; Scott Beattie W; Crowther MA; Callum JL; Chun R; Fremes SE; Lemieux J; McAlister VC; Muirhead BD; Murkin JM
Journal
Journal canadien d'anesthésie, Vol. 54, No. 7,
Publisher
Springer Nature
Publication Date
July 2007
DOI
10.1007/bf03022322
ISSN
0832-610X